ArticleLiver international : official journal of the International Association for the Study of the Liver2026
Clinical Exome Sequencing in Unexplained Hyperferritinemia Reveals Digenic and Oligogenic Inheritance Beyond Iron Homeostasis.
Article in Liver international : official journal of the International Association for the Study of the Liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Exome Sequencing in Unexplained Hyperferritinemia Reveals Digenic and Oligogenic Inheritance Beyond Iron Homeostasis.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsHyperferritinemia encompasses heterogeneous genetic etiologies beyond HFE-related hemochromatosis. Current guidelines recommend testing for rare hemochromatosis genes, yet no consensus exists on comprehensive genomic approaches. We aimed to characterise the genetic landscape of unexplained hyperferritinemia using clinical exome sequencing (CES) and evaluate genotype-phenotype correlations across functional pathways.
methodsIn this retrospective study (2019-2024), consecutive patients with unexplained hyperferritinemia after exclusion of secondary causes underwent CES. Patients with known HFE p.Cys282Tyr homozygosity were not referred for CES. Variant filtering was performed using the Genomics England panel for iron metabolism and the French network for rare liver diseases panel, combined with phenotype-driven analysis based on Human Phenotype Ontology annotations for iron-related phenotypes. Genes were categorised into four pathways: systemic iron sensing, iron transport and storage, hepatic metabolism and erythropoiesis.
resultsAmong 108 patients, CES identified at least one variant in 72 (66.7%), including 44 (40.7%) with likely pathogenic or pathogenic (LP/P) variants. HFE was the most frequently affected gene, followed by SERPINA1, ATP7B, and CP. Among patients without monogenic HFE alterations (n = 57), 21 (36.8%) carried variants, mainly affecting CP, ATP7B, SERPINA1 or GBA. Digenic or oligogenic inheritance was observed in 30.6% (22/72) of patients overall and in 20.5% (9/44) of those carrying LP/P variants, most frequently involving HFE-SERPINA1 and HFE-ATP7B combinations. Cross-pathway combinations occurred in 17 of 22 digenic patients (77.3%). The systemic iron sensing group exhibited significantly higher serum iron (p = 0.009) and transferrin saturation (p = 0.008).
conclusionsCES reveals genetic heterogeneity beyond the traditional Mendelian framework, with frequent non-HFE gene involvement and digenic inheritance and should be considered after exclusion of HFE p.Cys282Tyr homozygosity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.